Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Canada
|
| gptkbp:defunct |
2011
|
| gptkbp:foundedBy |
gptkb:Eugene_Melnyk
|
| gptkbp:foundedYear |
1991
|
| gptkbp:headquartersLocation |
Mississauga, Ontario, Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
Biovail Corporation
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:mergedInto |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:notableEvent |
class action lawsuit
SEC investigation |
| gptkbp:notableProduct |
gptkb:Wellbutrin_XL
gptkb:Cardizem_LA gptkb:Ultram_ER |
| gptkbp:numberOfEmployees |
~1000 (at peak)
|
| gptkbp:stockExchange |
gptkb:New_York_Stock_Exchange
gptkb:Toronto_Stock_Exchange |
| gptkbp:stockSymbol |
gptkb:BVF
|
| gptkbp:successor |
gptkb:Valeant_Pharmaceuticals_International,_Inc.
|
| gptkbp:website |
www.biovail.com
|
| gptkbp:bfsParent |
gptkb:Eugene_Melnyk
|
| gptkbp:bfsLayer |
6
|